Mark S. Albom
Mark S. Albom publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Lung Cancer Treatments and Mutations, Cancer therapeutics and mechanisms and Angiogenesis and VEGF in Cancer.
- World rank
- #2,196,889 of 7,710,434 ranked researchers
- Rank in United States
- #659,243 of 1,627,098
- Works
- 52
- Citations
- 1.5k
- Citations per work
- 28.0
What does Mark S. Albom research?
Mark S. Albom's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (22%), Chemistry (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2344.3%
- Medicine2344.3%
- Everything else1427.4%
- Life Sciences1122.1%
- Physical Sciences36.2%
- Chemistry36.2%
- 1Molecular Biology22% of their works
- 2Oncology20% of their works
- 3Pulmonary and Respiratory Medicine12% of their works
- 4Pathology and Forensic Medicine6% of their works
- 5Organic Chemistry6% of their works
- 6Neurology6% of their works
Research topics
Which keywords describe Mark S. Albom's research?
The keywords of their largest research topics: Chemotherapy, EGFR Mutations, Targeted Therapy, DNA, Topoisomerases, Breast Cancer, endothelial progenitor cells and HER2.
- Chemotherapy-Induced Peripheral Neuropathy
- Lymphoma
- Classification
- ALK
- VEGF
- Breast Cancer
- DNA
- EGFR Mutations
- Chemotherapy
- Targeted Therapy
- Topoisomerases
- HER2
- endothelial progenitor cells
- Neuroblastoma
- IL-6
- STAT3
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Chemotherapy212 topics
- EGFR Mutations131 topic
- Targeted Therapy131 topic
- DNA111 topic
- Topoisomerases111 topic
- Breast Cancer101 topic
- HER2101 topic
- VEGF101 topic
- endothelial progenitor cells101 topic
- ALK71 topic
- Neuroblastoma71 topic
- Classification61 topic
- IL-661 topic
- Lymphoma61 topic
- STAT361 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Taxanes41 topic
Where does Mark S. Albom work?
Mark S. Albom's main affiliation in the publication record is Brandywine Photonics (United States), United States.
How many publications and citations does Mark S. Albom have?
OpenAlex counts 52 works and 1,458 citations for Mark S. Albom, an h-index of 22, ranking #2,196,889 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark S. Albom. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.